Human Osteoblast-Like Cells Express Predominantly Steroid 5α-Reductase Type 1

    Sedika Issa, Dirk Schnabel, Maritta Feix, Lutz Wolf, Hans-Eckart Schaefer, David W. Russell, Hans-Udo Schweikert
    TLDR Human bone cells mainly produce a type 1 enzyme that may help regulate bone health.
    The study investigated the expression of 5alpha-reductase (5alpha-R) isozymes in human osteoblast-like cells (hOB cells) cultured from bone, using samples from six donors. It was found that these cells predominantly expressed the type 1 isozyme, as opposed to genital skin fibroblasts, which primarily expressed type 2. The study used selective inhibitors to determine the activity of these isozymes, finding that LY191704, a type 1 inhibitor, effectively blocked 5alpha-R activity in hOB cells, while finasteride, a type 2 inhibitor, was less effective. The research suggested that local production of dihydrotestosterone (DHT) in bone, catalyzed by 5alpha-R type 1, might play a role in bone homeostasis due to the presence of androgen receptors in bone cells.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 406 results
      Can I still save my hairline at age of 15?

      community Can I still save my hairline at age of 15?

      in General  499 upvotes 1 month ago
      A 15-year-old is concerned about hair loss, possibly at Norwood 2 or 3, and is using shampoos and conditioners recommended by a trichologist. Suggestions include considering topical minoxidil and consulting a doctor about topical anti-DHT treatments like finasteride or RU58841, but avoiding 5-alpha-reductase inhibitors at this age.

      community Why does it seem everyone favors finasteride over dutasteride?

      in Female  62 upvotes 1 year ago
      The conversation discusses preferences for hair loss treatments, specifically finasteride over dutasteride. Users share personal experiences, cost considerations, FDA approval status, and potential side effects, with some switching between treatments to find what works best for them.
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 1 year ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community Finasteride does deplete important nuero-active steroids

      in Research/Science  9 upvotes 2 years ago
      Finasteride can reduce neuroactive steroids, causing side effects like depression, anxiety, and sexual dysfunction. Some users experience persistent symptoms after stopping finasteride, while others use alternative treatments like topical solutions.

      community risks with finasteride and dutasteride

      in Research/Science  143 upvotes 5 months ago
      Finasteride and dutasteride have potential risks, including post-finasteride syndrome, but are commonly used for hair loss. RU58841, minoxidil, and needling are suggested as alternatives, though all treatments carry risks.

    Related Research

    5 / 5 results